Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 4 von 4
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2022-11, Vol.22 (7), p.864-870
2022
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Application of metagenomic next-generation sequencing for suspected infected pancreatic necrosis
Ist Teil von
  • Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2022-11, Vol.22 (7), p.864-870
Ort / Verlag
Philadelphia: Elsevier Limited
Erscheinungsjahr
2022
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
  • BackgroundMetagenomic next-generation sequencing (mNGS) is increasingly used for the clinical diagnosis of infectious diseases, but there is a paucity of data regarding the application of mNGS in the early diagnosis of infected pancreatic necrosis (IPN).ObjectiveTo investigate the clinical application value of mNGS in the pathogenic diagnosis of IPN.MethodsForty-two patients with suspected IPN were prospectively and consecutively enrolled from August 2019 to August 2021. Blood samples were collected for mNGS and microbial culture simultaneously during fever (T ≥ 38.5 °C). For patients who had indications of surgical interventions, peri-pancreatic specimens were collected for mNGS and microbial culture simultaneously during the first surgical intervention to confirm IPN. The clinical performance of mNGS and microbial culture were compared.ResultsA total of 21 patients (50.0%) were confirmed to have IPN during hospitalization. The sensitivity of blood mNGS was significantly higher than blood culture (95.2% vs. 23.8%, P < 0.001) in diagnosing IPN. The negative predictive value of blood mNGS was 90.0%. The turnaround time of mNGS was significantly shorter than that of microbial culture [(37.70 ± 1.44) vs. (115.23 ± 8.79) h, P < 0.01] and the average costs of mNGS accounted for 1.7% of the average total cost of hospitalization. The survival analysis demonstrates that the positive blood mNGS result was not associated with increased mortality (P = 0.119).ConclusionsWith more valuable diagnostic performance and shorter turnaround time, clinical mNGS represents a potential step forward in the early diagnosis of IPN.
Sprache
Englisch
Identifikatoren
ISSN: 1424-3903
eISSN: 1424-3911
DOI: 10.1016/j.pan.2022.07.006
Titel-ID: cdi_proquest_miscellaneous_2693777974

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX